Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1986 October; 79(10): 618–621.
PMCID: PMC1290508

Immunology of allergic rhinitis, or a nose for treatment.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (955K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Meltzer EO, Zeiger RS, Schatz M, Jalowayski AA. Chronic rhinitis in infants and children: etiologic, diagnostic, and therapeutic considerations. Pediatr Clin North Am. 1983 Oct;30(5):847–871. [PubMed]
  • Wihl JA, Brofeldt S, Grønborg H, Borum P, Mygind N. Blind study of basophilic cells in nasal smears from patients with grass pollen hay fever. Eur J Respir Dis Suppl. 1983;128(Pt 2):383–386. [PubMed]
  • Naclerio RM, Meier HL, Kagey-Sobotka A, Adkinson NF, Jr, Meyers DA, Norman PS, Lichtenstein LM. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis. 1983 Oct;128(4):597–602. [PubMed]
  • Naclerio RM, Proud D, Togias AG, Adkinson NF, Jr, Meyers DA, Kagey-Sobotka A, Plaut M, Norman PS, Lichtenstein LM. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med. 1985 Jul 11;313(2):65–70. [PubMed]
  • Rucci L, Cirri-Borghi B, Pantaleo T, Cagnoli A. Effects of vidian nerve stimulation on the nasal and maxillary sinus mucosa. A light and electron microscopic study. J Laryngol Otol. 1984 Jun;98(6):597–607. [PubMed]
  • Secher C, Kirkegaard J, Borum P, Maansson A, Osterhammel P, Mygind N. Significance of H1 and H2 receptors in the human nose: rationale for topical use of combined antihistamine preparations. J Allergy Clin Immunol. 1982 Sep;70(3):211–218. [PubMed]
  • Enerbäck L. Mast cells in rat gastrointestinal mucosa. I. Effects of fixation. Acta Pathol Microbiol Scand. 1966;66(3):289–302. [PubMed]
  • Kawabori S, Okuda M, Unno T. Mast cells in allergic nasal epithelium and lamina propria before and after provocation. An electron microscopic study. Clin Allergy. 1983 Mar;13(2):181–189. [PubMed]
  • Bisgaard H, Olsson P, Bende M. Leukotriene D4 increases nasal blood flow in humans. Prostaglandins. 1984 Apr;27(4):599–604. [PubMed]
  • Shaw RJ, Fitzharris P, Cromwell O, Wardlaw AJ, Kay AB. Allergen-induced release of sulphidopeptide leukotrienes (SRS-A) and LTB4 in allergic rhinitis. Allergy. 1985 Jan;40(1):1–6. [PubMed]
  • Shaw RJ, Walsh GM, Cromwell O, Moqbel R, Spry CJ, Kay AB. Activated human eosinophils generate SRS-A leukotrienes following IgG-dependent stimulation. Nature. 1985 Jul 11;316(6024):150–152. [PubMed]
  • Norman PS, Naclerio RM, Creticos PS, Togias A, Lichtenstein LM. Mediator release after allergic and physical nasal challenges. Int Arch Allergy Appl Immunol. 1985;77(1-2):57–63. [PubMed]
  • Kay AB. Specific and nonspecific triggers in bronchial asthma. J R Soc Med. 1985 Jan;78(1):82–85. [PMC free article]
  • Baumgarten CR, Togias AG, Naclerio RM, Lichtenstein LM, Norman PS, Proud D. Influx of kininogens into nasal secretions after antigen challenge of allergic individuals. J Clin Invest. 1985 Jul;76(1):191–197. [PMC free article] [PubMed]
  • Johnson LK, Longenecker JP, Baxter JD, Dallman MF, Widmaier EP, Eberhardt NL. Glucocorticoid action: a mechanism involving nuclear and non-nuclear pathways. Br J Dermatol. 1982 Nov;107 (Suppl 23):6–23. [PubMed]
  • Schleimer RP, MacGlashan DW, Jr, Gillespie E, Lichtenstein LM. Inhibition of basophil histamine release by anti-inflammatory steroids. II. Studies on the mechanism of action. J Immunol. 1982 Oct;129(4):1632–1636. [PubMed]
  • Schleimer RP, Schulman ES, MacGlashan DW, Jr, Peters SP, Hayes EC, Adams GK, 3rd, Lichtenstein LM, Adkinson NF., Jr Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. J Clin Invest. 1983 Jun;71(6):1830–1835. [PMC free article] [PubMed]
  • Robin JL, Seldin DC, Austen KF, Lewis RA. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids. J Immunol. 1985 Oct;135(4):2719–2726. [PubMed]
  • Brandon ML, Weiner M. Clinical investigation of terfenadine, a non-sedating antihistamine. Ann Allergy. 1980 Feb;44(2):71–75. [PubMed]
  • Van Wauwe J, Awouters F, Neimegeers CJ, Janssens F, Van Nueten JM, Janssen PA. In vivo pharmacology of astemizole, a new type of H1-antihistaminic compound. Arch Int Pharmacodyn Ther. 1981 May;251(1):39–51. [PubMed]
  • Bateman DN, Chapman PH, Rawlins MD. The effects of astemizole on histamine-induced weal and flare. Eur J Clin Pharmacol. 1983;25(4):547–551. [PubMed]
  • Howarth PH, Emanuel MB, Holgate ST. Astemizole, a potent histamine H1-receptor antagonist: effect in allergic rhinoconjunctivitis, on antigen and histamine induced skin weal responses and relationship to serum levels. Br J Clin Pharmacol. 1984 Jul;18(1):1–8. [PMC free article] [PubMed]
  • Howarth PH, Holgate ST. Comparative trial of two non-sedative H1 antihistamines, terfenadine and astemizole, for hay fever. Thorax. 1984 Sep;39(9):668–672. [PMC free article] [PubMed]
  • Roberts JA, Thomson NC. Attenuation of exercise-induced asthma by pretreatment with nedocromil sodium and minocromil. Clin Allergy. 1985 Jul;15(4):377–381. [PubMed]
  • Lal S, Malhotra S, Gribben D, Hodder D. Nedocromil sodium: a new drug for the management of bronchial asthma. Thorax. 1984 Nov;39(11):809–812. [PMC free article] [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press